The Biotech Startups Podcast is brought to you by Excedr. Excedr provides life science startups with equipment leases on founder-friendly terms to accelerate R&D and commercialization.Know anyone that needs lab equipment? Join Excedr’s referral program: Give Your Friends $1,000, and Earn $1,000 for Each Qualified Referral 💸.Get your unique referral link by going to: refer.excedr.com/ZTHETY.Part 1 of 4: Jon Chee hosts our latest guest, eMalick Njie, CEO of Ecotone AI, a company that is looking to use AI to find cures for rare inherited diseases. eMalick is an experienced scientist and entrepreneur who has focused on blending his expertise in neuroscience with his knowledge of AI. In addition to founding two AI companies, Ecotone and Genetic Intelligence, eMalick received his PhD in Neurobiology and Neuroscience from the University of Florida. His extensive and diverse experience from being a postdoctoral fellow at Columbia university to being the CEO of the AI thinktank NeuroStorm makes our conversation with him one you won’t want to miss.Join us this week to hear about:Growing up with hippie parents in the GambiaBeing in the first neuroscience class in the country at Northeastern UniversityLessons learned in one on one conversations with a CEOExperience working with Dr. Alice Ting while at MITSticking to his principles and leaving MITPlease enjoy Jon’s conversation with Dr. eMalick Njie!Subscribe to the podcast: https://podcasts.apple.com/us/podcast/the-biotech-startups-podcast/id1679591994Find Our Guest, Barbara Alcaraz Silva, at these links: https://www.linkedin.com/in/emalick-njie-ph-d-ab82348/ https://ecotone.ai/ Find Our Host, Jon Chee, at these links: https://www.linkedin.com/in/joncheehttps://www.excedr.comExcedr Socials & WebsiteLinkedIn: https://www.linkedin.com/company/excedr/ Youtube: https://www.youtube.com/@excedr Instagram: https://www.instagram.com/excedr_inc Twitter: https://twitter.com/ExcedrInc Facebook: https://www.facebook.com/excedr TikTok: https://www.tiktok.com/@excedr Podcast Website: https://www.thebiotechstartupspodcast.com/ Enriched Notes: Topics Mentioned:Ecotone AI: https://ecotone.ai/ Genetic Leap: https://www.genetic-leap.com/ Northeastern University: https://cos.northeastern.edu/behavioral-neuroscience/ Millennium Pharmaceuticals https://en.wikipedia.org/wiki/Takeda_Oncology Eli Lilly Joins Forces with AI Startup Genetic Leap in $409M Deal https://www.geneonline.com/eli-lilly-joins-forces-with-ai-startup-genetic-leap-in-409m-deal-centered-around-rna-targeted-drug-discovery/ Biotech Startup Support: https://www.excedr.com/resources-category/biotech-startup-supportPeople Mentioned:Dr. Alice Y. Ting: https://www.linkedin.com/in/alice-ting-a7689835/ Dr. Wendy Smith: https://www.linkedin.com/in/wendy-smith-80663714/ Mark Howort https://www.linkedin.com/in/mark-howarth-763112b1/Dr. Eric Kandel: https://www.columbiapsychiatry.org/profile/eric-kandel-md Dr. David Bruchelt https://www.linkedin.com/in/david-borchelt-42474623/ Dr. Wolfgang Streit: https://neuroscience.ufl.edu/profile/streit-wolfgang/ Timestamps:00:28 Intro02:12 Early upbringing in the Gambia, early childhood, and how his unusual hippie parents shaped him into the scientist and entrepreneur he is today04:32 Following his curiosity to his undergrad program Northeastern University to study the “unending book” of neuroscience06:51 Being part of the first neuroscience class in the country and starting the trend of working under Nobel Prize winners, and/or those trained by Nobel Laureates 11:17 First exposure to professional scientists while interning at Millennium Pharmaceuticals 14:03 Lessons learned during his humanizing one-on-one conversations with the CEO17:52 Comparing and contrasting his industry experience with his academia experience19:58 Getting to MIT after graduating from NEU and working with Dr. Alice Ting23:24 Dealing with challenging periods in your life and learning to persevere25:28 Memorable and humbling challenge while working in Dr. Ting’s lab30:18 “How do you lose your recommendation letter to MIT: 101” 32:38 Choosing to moving on to University of Florida36:51 OutroThe Biotech Startups Podcast is handcrafted by our friends over at: fame.so

The Biotech Startups Podcast is brought to you by Excedr. Excedr provides life science startups with equipment leases on founder-friendly terms to accelerate R&D and commercialization.Know anyone that needs lab equipment? Join Excedr’s referral program: Give Your Friends $1,000, and Earn $1,000 for Each Qualified Referral 💸.Get your unique referral link by going to: refer.excedr.com/ZTHETY.Part 4 of 4: Jon Chee hosts our latest guest, Barbara Alcaraz Silva, the Executive Director of Early Stage Life Sciences and Healthcare, Startup Banking at J.P. Morgan. Barbara brings a wealth of experience as a former researcher, entrepreneur, and industry veteran. She has worked extensively with startups and early-stage ventures. Her scientific background is in Telomeres and DNA Repair research. Prior to her role at J.P. Morgan, Barbara advised biotech and medtech companies at Manos Accelerator, served as a Senior Investment Fellow at Life Science Angels, and co-founded BioChron, an AI-driven biological aging tracking company. Her unique combination of scientific knowledge, business acumen, and investment/finance expertise makes her an invaluable resource for founders in the biotech space.Join us this week to hear about:Barbara’s unexpected pivot into bankingHer transition from SVB to J.P. MorganHer unique life sciences and entrepreneurial backgroundsThe importance of mentorship, resilience, and seizing unexpected opportunitiesNavigating the challenges of building a career in both science and financePlease enjoy Jon’s conversation with Barbara Alcaraz Silva!Subscribe to the podcast: https://podcasts.apple.com/us/podcast/the-biotech-startups-podcast/id1679591994Find Our Guest, Barbara Alcaraz Silva, at these links: https://www.linkedin.com/in/barbarasilvaucsf/https://www.jpmorgan.com/globalFind Our Host, Jon Chee, at these links: https://www.linkedin.com/in/joncheehttps://www.excedr.comExcedr Socials & WebsiteLinkedIn: https://www.linkedin.com/company/excedr/ Youtube: https://www.youtube.com/@excedr Instagram: https://www.instagram.com/excedr_inc Twitter: https://twitter.com/ExcedrInc Facebook: https://www.facebook.com/excedr TikTok: https://www.tiktok.com/@excedr Podcast Website: https://www.thebiotechstartupspodcast.com/ Enriched Notes: Topics Mentioned:SVB: https://www.svb.com/J.P. Morgan: https://www.jpmorgan.com/globalNucleate: https://www.nucleate.xyz/Women in Bio: https://womeninbio.org/How to Spin Out of Academia: https://www.excedr.com/resources/how-to-spin-out-of-academia-and-into-a-startupPatent Licensing for Biotechs: https://www.excedr.com/resources/how-patent-licensing-worksBiotech Startup Support: https://www.excedr.com/resources-category/biotech-startup-supportPeople Mentioned:Timestamps:00:28 Intro02:18 Pivoting from Life Sciences Angels to SVB10:24 Joining the Life Sciences practice and establishing the Early-Stage division13:22 Transitioning to Private Equity and J.P. Morgan16:16 The power of mentorship and mentor networks17:46 Barbara Reflects on her pivot from Life Sciences Angels to J.P. Morgan19:17 Why J.P. Morgan stands out and the impact of Barbara's group23:58 The importance of business partners who understand the Life Sciences27:55 How J.P. Morgan supports Growth-Stage companies30:57 Barbara’s 2-year vision34:34 Barbara’s shoutouts and advice to younger self37:00 OutroThe Biotech Startups Podcast is handcrafted by our friends over at: fame.so

The Biotech Startups Podcast is brought to you by Excedr. Excedr provides life science startups with equipment leases on founder-friendly terms to accelerate R&D and commercialization. Lease the equipment you need with Excedr. Extend your runway, hit your milestones.Know anyone who needs lab equipment? Join Excedr’s referral program.Give Your Friends $1,000, and Earn $1,000 for Each Qualified Referral 💸.Get your unique referral link by going to refer.excedr.com/ZTHETY.Part 3 of 4. My guest for this week’s episode is Barbara Alcaraz Silva, Executive Director of Early Stage Life Sciences and Healthcare, Startup Banking at J.P. Morgan. Barbara is a former researcher and entrepreneur, and an accomplished industry veteran. Her career has revolved around startups and early-stage ventures. As a graduate student, she focused on Telomeres and DNA Repair. Before joining J.P. Morgan, Barbara was an advisor for biotech and medtech companies at the Manos Accelerator, where she provided mentorship in business development, fundraising, and other key areas. She also served as a Senior Investment Fellow at Life Science Angels, where she invested in emerging biotechs and managed investor relationships. Additionally, Barbara co-founded BioChron, a company that leveraged AI and machine learning to track biological aging.Barbara’s dedication to fostering a strong community in the biotech space, combined with her expertise in science, business, and investing, makes her conversation invaluable for founders.Join us this week to hear about:Barbara’s transition from academia to entrepreneurship and industry Her experience co-founding Biochron, which built technologies to track biological aging using AI/MLThe challenges of early-stage company buildingHer time as a mentor at the Manos Accelerator, and investment experience in early-stage ventures as a Senior Fellow at Life Science AngelsAdvice for improving your investor pitch and connecting with the right peoplePlease enjoy my conversation with Barbara Alcaraz Silva.Find Our Guest, Barbara Alcaraz Silva, at these links: https://www.linkedin.com/in/barbarasilvaucsf/https://www.jpmorgan.com/globalFind Our Host, Jon Chee, at these links: https://www.linkedin.com/in/joncheehttps://www.excedr.comSocial & WebsiteLinkedIn: https://www.linkedin.com/company/excedr/ Youtube: https://www.youtube.com/@excedr Instagram: https://www.instagram.com/excedr_inc Twitter: https://twitter.com/ExcedrInc Facebook: https://www.facebook.com/excedr TikTok: https://www.tiktok.com/@excedr Podcast Website: https://www.thebiotechstartupspodcast.com/ Enriched Notes:Topics Mentioned:Harvard: https://www.harvard.edu/UCSF: https://www.ucsf.edu/Kaiser Permanente, Division of Research: https://divisionofresearch.kaiserpermanente.org/Manos Accelerator: https://manosaccelerator.com/Life Science Angels: https://www.lifescienceangels.com/The Column Group: https://www.thecolumngroup.com/How To Spin Out of Academia: https://www.excedr.com/resources/how-to-spin-out-of-academia-and-into-a-startupHow to Fund an R&D Lab: https://www.excedr.com/resources/rd-startup-funding-first-stepsTop Accelerators in Biotech: https://www.excedr.com/resources/biotech-acceleratorsTop Incubators in Biotech: https://www.excedr.com/resources/biotech-incubatorsAccelerator vs. Incubator: https://www.excedr.com/resources/accelerator-vs-incubatorTop VCs in Biotech: https://www.excedr.com/blog/top-vc-firms-for-biotechBiotech Funding Options: https://www.excedr.com/resources/biotech-startup-funding-optionsGrant Funding in Biotech: https://www.excedr.com/resources/grants-public-funding-biotech-startupsTimestamps:00:00 Intro01:54 The story behind Barbara’s decision to create a startup07:33 Experience as a Program Manager at UCSF10:43 Key lessons learned from running a startup and working as a PM16:03 Landing investment and advisory roles at the Manos Accelerator, Life Sciences Angels21:49 Crash course in investing and company assessment26:21 Advice for improving your investor pitch, connecting with the right people33:33 OutroThe Biotech Startups Podcast is handcrafted by our friends over at: fame.so

Barbara Alcaraz Silva, Executive Director at J.P. Morgan and co-founder of BioChron, shares her journey from academia to biotech. She discusses her experience selecting the right research lab and the pivotal role mentorship played in her career. Barbara highlights her transition to global opportunities through fellowships and the importance of lab culture. She also addresses funding challenges in research and offers insights into networking strategies for aspiring scientists in the competitive biotech landscape.

In this conversation, Barbara Alcaraz Silva, Executive Director at J.P. Morgan, shares her inspiring immigrant journey from Mexico to the U.S. at just 17. She discusses overcoming educational challenges and the pivotal role of mentorship in her success. Barbara also recounts her unique experience of presenting in Spanish at a national conference, reflecting her growth and connection to her roots. With a rich background as a scientist-entrepreneur, she emphasizes resilience and the power of seizing transformative opportunities in the biotech sector.

Part 4 of 4. My guest for this week’s episode is Derek Hennecke, a veteran biotech entrepreneur and board member with over 30 years of experience in the CDMO industry, whose mission is to support the biotech revolution and create value for patients, customers, and investors.In addition to his Board work, Derek previously held leadership positions at DSM and was the Founder and CEO of Xcelience, a Florida-based CDMO specializing in preformulation, micronization, analytical services, formulation development, cGMP manufacturing, and more. Derek eventually sold Xcelience to Capsugel (now Lonza) in 2016. His extensive pharma and cell therapy expertise makes for an insightful conversation that founders can learn from.Join us this week and hear about:The process of building and scaling Xcelience, from leveraging innovative technology to disrupt the market to navigating the impact of the 2008 RecessionDerek’s experience with strategic buy-side and sell-side transactions His commitment to continuous learningHis transition into investing and work as a board memberPlease enjoy my conversation with Derek Hennecke.Find Our Guest, Derek Hennecke, at these links: https://www.linkedin.com/in/hennecke/https://kincellbio.com/Find Our Host, Jon Chee, at these links: https://www.linkedin.com/in/joncheehttps://www.excedr.comSocial & WebsiteLinkedIn: https://www.linkedin.com/company/excedr/ Youtube: https://www.youtube.com/@excedr Instagram: https://www.instagram.com/excedr_inc Twitter: https://twitter.com/ExcedrInc Facebook: https://www.facebook.com/excedr TikTok: https://www.tiktok.com/@excedr Podcast Website: https://www.thebiotechstartupspodcast.com/ Enriched Notes:Topics Mentioned:Xcelience: https://www.linkedin.com/company/xcelience-llc/MicroSize: https://www.microsize.com/Capsugel: https://en.wikipedia.org/wiki/CapsugelLonza (Capsugel’s Parent Company): https://www.lonza.com/Austin Px: https://www.austinpx.com/Micronization: https://en.wikipedia.org/wiki/MicronizationBiotech Partnerships: https://www.excedr.com/blog/how-biotech-partnerships-support-researchM&A Strategies in Biotech: https://www.mckinsey.com/capabilities/m-and-a/our-insights/life-sciences-m-and-a-shows-new-signs-of-lifeBiotech Funding Options: https://www.excedr.com/resources/biotech-startup-funding-optionsMarketing and Sales Strategies in Biotech: https://www.excedr.com/blog/marketing-sales-strategies-for-biotechsHow To Run an Efficient Board Meeting: https://www.excedr.com/resources/how-to-run-an-effective-board-meetingElephant Slides: https://rapport.bio/all-stories/elephant-in-boardroomTimestamps:00:28 Intro01:48 Disrupting the market with Xcelience03:34 Derek’s M&A experience and acquisition strategy on the buy-side04:36 Financing Xcelience’s acquisition of another micronization company06:32 Derek’s sell-side experience with Capsugel12:03 Challenges of work and life post-acquisition; Working with Lonza14:32 Going back to school, starting as an investor, and transitioning to board work17:35 Bringing confidence and decision-making skills to board member roles20:21 Running effective board meetings and finding CEO mentorship26:53 Final reflections and Derek’s advice for founders30:11 OutroThe Biotech Startups Podcast is handcrafted by our friends over at: fame.so

As a podcast listener, you can redeem exclusive discounts with a growing list of biotech vendors and get $500 off your first equipment lease by using promo code “TBSP” on https://www.excedr.com/rewards.Part 3 of 4. My guest for this week’s episode is Derek Hennecke, a veteran biotech entrepreneur and board member with over 30 years of experience in the CDMO industry, whose mission is to support the biotech revolution and create value for patients, customers, and investors.In addition to his Board work, Derek previously held leadership positions at DSM and was the Founder and CEO of Xcelience, which he eventually sold to Capsugel Lonza in 2016. Xcelience was a Florida-based CDMO specializing in preformulation, micronization, analytical services, formulation development, cGMP manufacturing, and more. His extensive pharma and cell therapy expertise makes for an insightful conversation that founders can learn from.Join us this week and hear about:Derek’s transition from commercial roles to Operations, managing a challenging site in Egypt, and the teamwork that turned it aroundHis move to a Biologics site in Montreal and the hurdles he faced there overseeing GMP OperationsThe start of his entrepreneurial journey: buying a portion of a business and founding Xcelience.Please enjoy my conversation with Derek Hennecke.Find Our Guest, Derek Hennecke, at these links: https://www.linkedin.com/in/hennecke/https://kincellbio.com/Find Our Host, Jon Chee, at these links: https://www.linkedin.com/in/joncheehttps://www.excedr.comSocial & WebsiteLinkedIn: https://www.linkedin.com/company/excedr/ Youtube: https://www.youtube.com/@excedr Instagram: https://www.instagram.com/excedr_inc Twitter: https://twitter.com/ExcedrInc Facebook: https://www.facebook.com/excedr TikTok: https://www.tiktok.com/@excedr Podcast Website: https://www.thebiotechstartupspodcast.com/Enriched Notes:Topics Mentioned:MDS Pharma Services: https://www.mdsps.com/Xcelience: https://www.linkedin.com/company/xcelience-llc/GMP Operations Roles: https://www.linkedin.com/advice/0/how-do-you-identify-common-gmp-roles-responsibilities-skills-gmpGMP Practices: https://safetyculture.com/topics/gmp/GMP vs. GLP: https://www.excedr.com/resources/gmp-vs-glp-whats-the-differenceMatrix Organizations: https://www.pmi.org/learning/library/matrix-organization-structure-reason-evolution-1837Sales-Leasebacks (SLB): https://www.excedr.com/blog/what-is-a-sale-leasebackEquipment Leasing: https://www.excedr.com/leasingTimestamps:00:00 Intro01:50 Starting a role in Operations04:01 Derek’s move to Egypt; Improving safety, performance, and cost structure08:03 Scaling the Egypt site and expanding into other markets; Improving product quality and employee safety10:01 Moving back to Montreal, Canada; Dealing with a site failure, deciding to leave the company13:50 Lessons learned from leaving, the importance of saying “no,” and communicating clearly20:16 Becoming VP of GMP Operations of MDS Pharma; Overseeing multiple locations25:08 Navigating the hurdles of a closing business; Buying one of the units in Tampa, Florida27:45 Derek’s jump into entrepreneurship: Founding Xcelience30:00 Early days of running the company, looking into a sales-leaseback, and securing capital38:21 OutroThe Biotech Startups Podcast is handcrafted by our friends over at: fame.so

As a podcast listener, you can redeem exclusive discounts with a growing list of biotech vendors and get $500 off your first equipment lease by using promo code “TBSP” on https://www.excedr.com/rewards.Part 2 of 4. My guest for this week’s episode is Derek Hennecke, a veteran biotech entrepreneur and board member with over 30 years of experience in the CDMO industry, whose mission is to support the biotech revolution and create value for patients, customers, and investors.In addition to his Board work, Derek previously held leadership positions at DSM and was the Founder and CEO of Xcelience, which he eventually sold to Capsugel Lonza in 2016. Xcelience was a Florida-based CDMO that specialized in preformulation, micronization, analytical services, formulation development, cGMP manufacturing, and more. His extensive expertise in pharma and cell therapy makes for an insightful conversation that founders can learn from.Join us this week and hear about:Derek’s early challenges and financial hurdles he faced after moving to Europe for his MBAHis first role in business developmentHis managing transition, learning the ropes of leadership, and his joint venture experience in MexicoDerek’s intricacies of managing a matrix organization and his experience as a product managerPlease enjoy my conversation with Derek Hennecke.Find Our Guest, Derek Hennecke, at these links: https://www.linkedin.com/in/hennecke/https://kincellbio.com/Find Our Host, Jon Chee, at these links: https://www.linkedin.com/in/joncheehttps://www.excedr.comSocial & WebsiteLinkedIn: https://www.linkedin.com/company/excedr/ Youtube: https://www.youtube.com/@excedr Instagram: https://www.instagram.com/excedr_inc Twitter: https://twitter.com/ExcedrInc Facebook: https://www.facebook.com/excedr TikTok: https://www.tiktok.com/@excedr Podcast Website: https://www.thebiotechstartupspodcast.com/ Timestamps:00:28 Intro01:50 Episode starts, starting with business development with Gist-brocades and then quickly moving to area business development manager03:00 Derek’s definition of business development and tips and tricks06:27 The trials of traveling back and forth to North America and Derek’s first time managing a team11:20 The challenges of moving and running a joint venture in Mexico, the willingness to do new things16:47 The balancing act of leading a 50/50 venture, communication, and building trust24:18 Strategy to expand almost worldwide, buying a penicillin factory in Mexico City26:59 Becoming a product manager and the roles it entailed, defining a matrix organization31:18 OutroThe Biotech Startups Podcast is handcrafted by our friends over at: fame.so

As a podcast listener, you can redeem exclusive discounts with a growing list of biotech vendors and get $500 off your first equipment lease by using promo code “TBSP” on https://www.excedr.com/rewards.Part 1 of 4. My guest for this week’s episode is Derek Hennecke, a veteran biotech entrepreneur and board member with over 30 years of experience in the CDMO industry, whose mission is to support the biotech revolution and create value for patients, customers, and investors.In addition to his Board work, Derek previously held leadership positions at DSM and was the Founder and CEO of Xcelience, which he eventually sold to Capsugel Lonza in 2016. Xcelience was a Florida-based CDMO that specialized in preformulation, micronization, analytical services, formulation development, cGMP manufacturing, and more. His extensive expertise in pharma and cell therapy makes for an insightful conversation that founders can learn from.Join us this week and hear about:Derek’s childhood and his early interest in history and scienceHis academic journey in microbiology at the University of Alberta, where he shifted from chemistry to biology, and his eventual move into sales.His MBA experience in the Netherlands and his current outlook on the degree.Please enjoy my conversation with Derek Hennecke.Find Our Guest, Derek Hennecke, at these links: https://www.linkedin.com/in/hennecke/https://kincellbio.com/Find Our Host, Jon Chee, at these links: https://www.linkedin.com/in/joncheehttps://www.excedr.comSocial & WebsiteLinkedIn: https://www.linkedin.com/company/excedr/ Youtube: https://www.youtube.com/@excedr Instagram: https://www.instagram.com/excedr_inc Twitter: https://twitter.com/ExcedrInc Facebook: https://www.facebook.com/excedr TikTok: https://www.tiktok.com/@excedr Podcast Website: https://www.thebiotechstartupspodcast.com/ Timestamps00:28 Intro02:13 Episode starts, Derek's early upbringing as a military kid and learning how to adapt to moving every 4 years06:33 Having an interest in history but ultimately falling in love with science, Studying microbiology as an undergraduate at the University of Alberta08:50 Undergraduate lab experience14:04 Professors and mentors who were influential15:40 Next steps after Undergraduate microbiology, going from academia to sales at Boehringer Mannheim22:02 Introvert vs. Extrovert in Sales24:28 Decision to move to the Netherlands to pursue a masters in business28:20 The rarity of getting an MBA and using it to move into a new country to network30:18 OutroThe Biotech Startups Podcast is handcrafted by our friends over at: fame.so

As a podcast listener, you can redeem exclusive discounts with a growing list of biotech vendors and get $500 off your first equipment lease by using promo code “TBSP” on https://www.excedr.com/rewards.Part 4 of 4. My guest for this week’s episode is Doug Drysdale, CEO at Cybin. Cybin is a clinical-stage biopharma company on a mission to create safe and effective psychedelic-based therapeutics. Doug is an experienced investor, Corporate Director and CEO, who has chaired the Board of a NASDAQ-listed company and, as a CEO for the past 12 years, has built and turned around 3 pharma companies. During his 30+ years of experience in the healthcare sector, he has formed cohesive management teams, recruited board members, completed 16 corporate acquisitions across three continents and has raised and invested around $4 billion of both public and private capital. Before Cybin, Doug was Commercial Products Manager at DuPont Merck, Director of BD at Elan, VP of M&A at Actavis Group, CEO of Norwich Pharmaceuticals and Alvogen, CEO of Pernix Therapeutics, and CEO of Tedor Pharma. His extensive background as a seasoned executive, investor, and turn-around specialist gives him a wide range of experiences that founders can learn from. Join us this week and hear about:Doug’s first-time experience running a public company: the challenges of hitting quarterly numbers and juggling the pressure of share price volatilityHis move to Cybin, a startup transforming psychiatric treatments through psychedelic compoundsCybin’s recent progress, including some key acquisitions, taking the company public, and their breakthrough therapies in depression and anxiety.Please enjoy my conversation with Doug Drysdale.Timestamps:00:28 Intro01:50 Doug’s first experience running a public company, Pernix Therapeutics06:51 Leaving Pernix for a private company and a break from public scrutiny08:22 Joining Cybin, going public, and raising $300MM; quickly developing therapy and IP assets11:34 Cybin’s mission and focus; the co-founders and the team behind the technology15:08 The DEA’s outlook on psychedelics and the development of SSRI alternatives17:26 Doug’s experience working with the FDA19:39 Cybin’s IP and partnership strategies; building out a core team and retaining talent24:00 Cybin’s 2-year vision24:58 Shoutouts and advice to 21-year old self26:37 OutroFind Our Guest, Doug Drysdale, at these links: https://www.linkedin.com/in/dougdrysdale/https://cybin.com/Find Our Host, Jon Chee, at these links: https://www.linkedin.com/in/joncheehttps://www.excedr.comSocial & WebsiteLinkedIn: https://www.linkedin.com/company/excedr/ Youtube: https://www.youtube.com/@excedr Instagram: https://www.instagram.com/excedr_inc Twitter: https://twitter.com/ExcedrInc Facebook: https://www.facebook.com/excedr TikTok: https://www.tiktok.com/@excedr Podcast Website: https://www.thebiotechstartupspodcast.com/ Enriched Notes:Topics Mentioned:Pernix Therapeutics: https://en.wikipedia.org/wiki/Pernix_Therapeutics_HoldingsCybin: https://cybin.com/Intellectual Property 101: https://www.excedr.com/resources/intellectual-property-guideSSRIs: https://www.mayoclinic.org/diseases-conditions/depression/in-depth/ssris/art-20044825Psychedelic Compounds for Therapies: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4592297/Pharmacokinetics: https://www.ncbi.nlm.nih.gov/books/NBK557744/Understanding Psilocybin and DMT Treatments for Depression: https://www.hopkinsmedicine.org/news/newsroom/news-releases/2022/02/psilocybin-treatment-for-major-depression-effective-for-up-to-a-year-for-most-patients-study-showsCybin’s Developmental Pipeline: https://cybin.com/development-pipeline/DEA’s outlook on psychedelics: https://www.cato.org/regulation/spring-2023/psychedelics-dea-regulating-religionGuide to FDA Drug Approval Process: https://www.excedr.com/blog/fda-drug-approval-process-guide IP Strategy for Biotechs: https://www.excedr.com/resources/intellectual-property-strategy-for-biotechsBiotech Partnerships: https://www.excedr.com/blog/how-biotech-partnerships-support-researchThe Biotech Startups Podcast is handcrafted by our friends over at: fame.so